Cytokinetics Presents Positive Results From Cohort 4 of
Treatment with Aficamten Resulted in Significant Improvements in Heart Failure Symptoms and Cardiac Biomarkers in Patients with Non-Obstructive...
Treatment with Aficamten Resulted in Significant Improvements in Heart Failure Symptoms and Cardiac Biomarkers in Patients with Non-Obstructive...
– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG...
Coverage Includes 23 Games between Saturday, March 4th and Sunday, March 12th, 2023...
NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today...
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Warner Music Group Corp. (“Warner Music Group” or “WMG”) announced today that Robert Kyncl, Chief Executive...
CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic...
Almaty, Kazakhstan, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Oxus Acquisition Corp. (Nasdaq: OXUS) (the “Company”) today announced that the extraordinary...